Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
15.9%
% of FXH's 83 holdings also in BBP
25.0%
% of BBP's 55 holdings also in FXH
Overlap by Weight
Sector Drift (FXH minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FXH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ROIVANT SCIENCES LTD. | 2.2% | 1.9% | 1.9% |
 |
EXELIXIS INC | 1.7% | 1.7% | 1.7% |
|
INCYTE CORP | 1.6% | 1.7% | 1.6% |
|
UNITED THERAPEUTICS CORP | 2.3% | 1.6% | 1.6% |
|
GILEAD SCIENCES INC | 1.6% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
FXH Overweight Relative to BBP
|
SHOCKWAVE MEDICAL, INC. | 2.3% |
|
CIGNA CORPORATION | 2.2% |
|
CARDINAL HEALTH INC | 2.2% |
|
REPROS THERAPEUTICS INC | 2.2% |
|
ENCOMPASS HEALTH CORPORATION | 2.1% |
|
PREMIER INC-CLASS A | 2.1% |
|
VIATRIS, INC. | 2.1% |
|
ELI LILLY & CO | 2.1% |
|
NATERA INC | 2.1% |
|
DAVITA INC | 2.1% |
FXH Underweight Relative to BBP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.6% |
|
AGIOS PHARMACEUTICALS INC | -2.5% |
|
ADMA BIOLOGICS, INC. | -2.5% |
|
CRISPR THERAPEUTICS AG | -2.4% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.1% |